Ask which scientific breakthrough has loomed largest in the public imagination in the past few years, and most will pick artificial intelligence in the form of large language models. But a close second, and arguably deserving a joint first place, are GLP-1 receptor agonists, the compounds used in drugs such as Ozempic and Wegovy, prescribed originally for diabetes but now hugely popular for weight management.
如果你问过去几年哪项科学突破最深植于公众想象，大多数人会选择以大型语言模型为代表的人工智能。不过紧随其后、甚至可以说并列第一的，是GLP-1受体激动剂——这类化合物用于Ozempic和Wegovy等药物，最初用于治疗糖尿病，但如今在体重管理方面非常受欢迎。
您已阅读11%（540字），剩余89%（4280字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。